Delivery of modulators of glutamate-mediated neurotransmission to the inner ear
US7589110B2 · kind B2 · utility
12Cited by
2References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 6, 2002 |
| Grant date | Sep 15, 2009 |
| Priority date | — |
| Expiry date | Jun 12, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods and devices for local delivery of agents that modify glutamate-mediated neurotransmission to the inner ear for treatment of inner ear disorders caused by glutamate-induced hearing loss and/or tinnitus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.